CareDx (CDNA) has provided an update.
CareDx, Inc. recently bolstered its leadership by appointing seasoned finance professional R. Bryan Riggsbee to its Board as a Class II director and Chairperson of the Audit and Finance Committee. With a robust background that includes a decade at LabCorp and a tenure as CFO of Myriad Genetics, Riggsbee brings a wealth of experience to the role. He is set to receive both cash compensation and stock-based incentives, aligning his interests with the company’s success. This strategic move aims to strengthen CareDx’s financial oversight and governance, signaling positive momentum for the company’s future endeavors.
For detailed information about CDNA stock, go to TipRanks’ Stock Analysis page.
